Evosep webinar
Industrialized Drug Discovery with the Evosep One
Thursday, mARCH 27th at 4:00 pm CET (10:00 EST)
Drug discovery has advanced into a highly complex and regulated process, requiring the seamless integration of biology, chemistry, and pharmacology. Over the past decades, the increasing demand for preclinical validation, clinical trials, and regulatory approvals has emphasized the need for more efficient analytical workflows.
To accelerate innovation while maintaining data quality, high-throughput and robust analytical methods are essential. In this webinar, we explore how Evosep One is shaping industrialized drug discovery by enabling higher sensitivity, reproducibility, and scalability—critical factors in developing new drug applications and biologics license applications.
Join us to learn how industrialized proteomics can enhance drug discovery pipelines, reduce bottlenecks, and bring safer treatments to patients faster.
Speakers
Ashok DongrE, Senior Director & Head of Proteomics at Bristol-Myers Squibb
